Thrombotic events in metastatic colorectal cancer patients treated with leucovorin, fluorouracil and irinotican (FOLFIRI) plus bevacizumab

Humaid O. Al-Shamsi1,2,3, Abdulaziz Al Farsi1, Mahraz Anjum2, Hua Shen2, Kevin Zbuk1, Richard J. Cook2, Lori-Ann Linkins4, Pierre Major1

1Department of Oncology, McMaster University, Hamilton, Ontario, Canada; 2Department of Statistics and Actuarial Science, University of
Waterloo, Waterloo, Ontario, Canada; 3Department of Medicine, Sheikh Zayed Military Hospital, Abu Dhabi, United Arab Emirates; 4Department of Medicine, McMaster University, Hamilton, Ontario, Canada Correspondence to: Humaid O. Al-Shamsi, MD, FRCPC, FACP. Department of Gastrointestinal Medical Oncology, Unit 426, 1515 Holcombe Blvd, Houston, TX 77030, USA. Email: halshamsi@mdanderson.org.

Submitted Jan 29, 2015. Accepted for publication Feb 13, 2015.

Breast Surgery Dubai UAE Sadir Alrawi MD FRCSEd FRCSEng, Best Oncology Team for ColoRectal Surgery, Head & Neck Surgery, Liver & Pancreas Surgery, Melanoma & Sarcoma, HIPEC, Breast Surgery, Lung Surgery, Esophageal & Stomach, Urological Oncology, Gynecological Oncology, with American Boarded Medical Oncologists